SS
OLMA icon

SBI Securities’s Olema Pharmaceuticals OLMA Stock Holding History

SBI Securities’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$763 Hold
61
– – ﹤0.01% 2896
2026
Q1 		$910 Hold
61
– – ﹤0.01% 2689
2025
Q4 		$1.52K Buy
61
+10
+20% +$178 ﹤0.01% 2494
2025
Q3 		$499 Hold
51
– – ﹤0.01% 2968
2025
Q2 		$217 Buy
51
+16
+46% +$71 ﹤0.01% 3281
2025
Q1 		$132 Hold
35
– – ﹤0.01% 3361
2024
Q4 		$204 Buy
+35
New +$350 ﹤0.01% 3233

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

SBI Securities's OLMA Position: Q2 2026 in Review

SBI Securities held its Olema Pharmaceuticals (OLMA) position steady in Q2 2026 at 61 shares worth $763. The position accounts for ﹤0.01% of the portfolio, ranked #2896.

SBI Securities first reported a position in OLMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.52K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • SBI Securities held 61 shares of Olema Pharmaceuticals worth $763 as of Q2 2026.
  • SBI Securities left its Olema Pharmaceuticals share count unchanged in Q2 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2896 holding.
  • SBI Securities first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Olema Pharmaceuticals position peaked at $1.52K in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.